The renin-angiotensin system plays a critical role in blood pressure control and body fluid and electrolyte homeostasis. 
T
he renin angiotensin system (RAS), a potent regulator of blood pressure, plays a major role in the pathogenesis of cardiovascular diseases (1, 2) . Emerging evidence suggests that angiotensin (Ang) II is not the only active peptide of the RAS. Other members of the system; Ang III [Ang- (2) (3) (4) (5) (6) (7) (8) ], Ang IV [Ang- (3) (4) (5) (6) (7) (8) ], and Ang-(1-7) may also mediate the actions of the RAS (3) . The vascular and baroreflex actions of Ang-(1-7) counteract those of Ang II (4, 5) . Studies using the selective Ang-(1-7) antagonist A-779 (6, 7) provide evidence for an Ang-(1-7) receptor distinct from the classical Ang II receptors AT 1 and AT 2 (4, 7) .
The Mas protooncogene, first detected in vivo by tumorigenic properties originating from rearrangement of its 5Ј flanking region (8, 9) , encodes a protein with seven hydrophobic transmembrane domains, considered to be an ''orphan'' G proteincoupled receptor (10) . Whereas the tumorigenic properties of Mas seem to be negligible, transfection studies suggested that the Mas gene encodes an Ang II receptor (11) . But, Ang II-induced intracellular Ca 2ϩ responses in Mas-transfected cells occurred only in cells endogenously expressing the Ang II receptor AT 1 (12) . Other experiments indicated that Mas modulates intracellular signaling of AT 1 after Ang II stimulation (13) .
In this study, we performed radioligand binding with autoradiography on mouse kidneys, cell-specific binding, and functional studies in vitro, physiological and pharmacological ex vivo and in vivo experiments in Mas-deficient mice to demonstrate that the G protein-coupled receptor Mas binds Ang- (1) (2) (3) (4) (5) (6) (7) and is involved in the biologic actions of this heptapeptide.
Materials and Methods
In Vitro Receptor Autoradiography of 125 I-Angiotensin Binding to Mouse Kidneys. Kidneys of Mas-deficient mice (14) and Mas WT animals were snap-frozen in isopentane cooled with liquid nitrogen. Sections (10 m) were serially cut starting from the central area of the kidney, mounted onto 1%-gelatinized slides and dried at 4°C. Sections were stored frozen at -80°C.
The sections were thawed to ambient (22-24°C) temperature and preincubated in the following assay buffers. For Ang II receptor binding: 150 mM NaCl͞5 mM EDTA͞0.1 mM bacitracin͞50 mM NaPO 4 , pH 7.2; for Ang-(1-7) binding: 10 mM Na-phosphate buffer, pH 7.4͞120 mM NaCl͞5 mM MgCl 2 ͞0.2% BSA͞0.005% bacitracin; and for Ang IV binding: 150 mM NaCl͞5 mM EDTA͞50 M Plummer's inhibitor (DL-2-mercaptomethyl-3-guanidoethylthiopropanoic acid)͞100 M phenylmethylsulfonyl f luoride͞20 M bestatin͞1 mg͞ml BSA͞50 mM Tris⅐HCl, pH 7.4 for 30 min.
Sections were subsequently incubated with radioligand. For Ang II receptors: assay buffer with 0.5 nM After incubation, sections were rinsed (five times for 1 min each in assay buffer) preceded and succeeded by two quick dips in distilled water. Sections were dried under a stream of air at 22-24°C and exposed to autoradiographic film (Kodak Biomax MR-1) for 3 (Ang II), 14 [Ang-(1-7)], and 3 (Ang IV) days at Ϫ20°C. Water Diuresis. Water diuresis was induced by i.p. injection of distilled water (0.5 ml͞10 g). WT and Mas-knockout mice received a water load combined in the same injection with vehicle (0.9% NaCl 0.005 ml͞10 g, n ϭ 8 for each group) or Ang-(1-7) (4 pmol͞10 g, n ϭ 8 for Mas-knockout and n ϭ 9 for WT mice).
In other experiments, the two subsets of mice were subjected to water load combined with i.p. injection of vehicle (0.9% NaCl 0.005 ml͞10 g, n ϭ 8 for each group) or arginine-vasopressin (AVP; 2 pmol͞10 g, n ϭ 6 for each group). Immediately after i.p. injection, mice were placed in metabolic cages and their urine output measured for 60 min (urine recovery rate evaluated in previous experiments was Ͼ85%).
Mouse Aortic Ring Preparation and Mounting. Rings (2-3 mm) from descending thoracic aorta containing a functional endothelium, cleared of adipose and connective tissue, were equilibrated in gassed (95% O 2 ͞5% CO 2 ) Krebs-Henseleit solution for 1 h. During this time, the incubation medium was changed every 15 min. After equilibration, two contractile responses were evoked by submaximal concentrations of phenylephrine (0.3 M) to elicit reproducible responses. The vasorelaxant effect of Ang-(1-7) was measured in rings precontracted with 0.1 M phenylephrine. Ang-(1-7) (0.0001-0.3 M) was added in increasing cumulative concentrations once the response to phenylephrine stabilized. The presence of a functional endothelium was assessed by the ability of acetylcholine (10 M) to induce Ͼ70% relaxation of vessels precontracted with phenylephrine (0.3 M). Mechanical activity, recorded isometrically by a force transducer (World Precision Instruments, Sarasota, FL), was fed to an amplifier-recorder (Model TMB-4; World Precision Instruments) and to a computer equipped with an analog-to-digital converter board (AD16JR; World Precision Instruments), using CVMS data acquisition͞recording software (World Precision Instruments).
Statistics. Statistical analyses for radioligand-binding studies used paired or unpaired t tests, with Aspin-Welch correction for heterogeneity of variance. Statistical analyses of the water diuresis experiments used a nonpaired t test. Comparison of the effects of peptides on AA release was analyzed by a nonpaired t test or one-way ANOVA followed by Newman-Keuls test. Two-way ANOVA was used to compare the relaxation produced by Ang-(1-7) in mice aortic rings.
Results
As summarized in Fig. 1C, (Fig. 1 A Center and C) , with low binding to the AT 2 receptor subtype ( Fig. 1 A Right and C) . Representative autoradiograms of 125 I-Ang-(1-7) binding are shown in Fig. 1B . Low-level specific 125 I-Ang (1-7) binding was observed in kidneys of Mas-WT mice. Specific 125 I-Ang-(1-7) binding for the entire WT group was 14.1 Ϯ 4.5 fmol͞g (mean Ϯ SEM). Nonspecific binding in Mas-deficient kidney sections tended to be higher than total binding in these kidneys and the average specific binding was Ͻ0 (Fig. 1C) . However, this difference was not statistically significant (paired t ϭ 1.39, df ϭ 5). Specific 125 I-Ang (1-7) binding was significantly greater in the kidneys of WT compared with the Mas-deficient mice (P ϭ 0.029, one-tailed t test with Aspin-Welch correction). Total 125 I-Ang-(1-7) binding in WT kidneys was significantly greater than nonspecific binding (paired t ϭ 3.12, df ϭ 5, P ϭ 0.0262).
Binding of 125 I-Ang-(1-7) was preserved in kidney slices of AT 1 -(18) and AT 2 -(19) knockout mice (data not shown). Additionally, slices of normal and Mas-knockout mice showed no major differences in the binding of 125 I-Ang IV (Fig. 1D) .
To further examine the specificity of Ang-(1-7) binding to Mas, binding studies were performed by using Mas-transfected CHO cells. To evaluate the functional significance of Ang-(1-7), CHO and COS cells transfected with Mas were treated with varying concentrations of Ang-(1-7) and examined for AA release. Ang (1-7) caused a concentration-dependent increase in (Fig. 3) . This effect was blocked by the Ang (1-7) antagonist A779. Ang II at 10 Ϫ8 M produced no increase in AA release, whereas nontransfected CHO cells did not respond either to Ang-(1-7) or Ang II. Ang-(1-7) also stimulated AA release in Mas-transfected COS cells (Fig. 4) . This release was not affected by irbesartan or PD 123319 (10 Ϫ8 M). To further determine the functional significance of Ang-(1-7), we examined its antidiuretic effect after water loading in mice, because it exerts potent antidiuresis in water-loaded rats (20) . Antidiuretic activity also was seen in Mas WT mice (Fig. 5A) . The reduced urine volume in control mice was associated with an increase in urine osmolality (Fig. 5B) . Corroborating the binding and AA release studies, the antidiuretic effect of Ang-(1-7), at a dose reducing 80% of the urinary flow in water-loaded control mice, was completely abolished in Mas-knockout animals. In contrast, AVP retained its antidiuretic activity in Mas-knockout mice (Fig. 5C) . Mas-deficient mice showed no significant changes in basal renal function parameters (data not shown).
Because Ang-(1-7) causes vasorelaxation in a number of vascular beds (5), we examined the effects of Ang-(1-7) on relaxation of aortic rings derived from WT and Mas-deficient mice. The endothelium-dependent relaxation in WT animals [E max ϭ 40.8 Ϯ 8.9%; (P Ͻ 0.001)] was abolished in the aortic rings of Mas-knockout mice (Fig. 6 ).
Discussion
To clarify the role of Mas in Ang II binding and signaling, we performed radioligand-binding studies with Ang II in kidney slices of WT and Mas-deficient mice (14) . Ang II binding (mainly to AT 1 receptors) was unaltered in kidneys of Mas-knockout mice compared with that of WT, indicating no influence of Mas on AT 1 binding. However, Ang-(1-7) binding was absent in Mas-knockout mice, indicating that Mas is an Ang-(1-7) recep- -(1-7) induced a significant increase in 3 H-AA release that was completely abolished with A-779 in both COS and CHO cells transfected with Mas. The specificity of the Ang-(1-7)-Mas axis is confirmed by the fact that neither an AT 1 nor an AT 2 antagonist blocked this release. These results are consistent with previously reported findings in rabbit smooth muscle cells (23) , in which the PLA 2 ͞ cyclooxygenase pathway contributed to the physiological effects of Ang-(1-7) through an interaction with its own receptor subtype (5, 24) .
Our data in mice reproduced our previous findings of an antidiuretic action of Ang-(1-7) in water-loaded rats (20) . The reduced urinary volume in control mice corresponded to a rise in its osmolality, indicating that the antidiuretic effect of Ang-(1-7) results from increased water reabsorption. This antidiuretic effect is blunted in Mas-deficient animals. Furthermore, the antidiuretic activity of vasopressin was preserved in Masknockout mice, excluding nonspecific changes in their renal function. Thus, the failure of Ang-(1-7) to display its antidiuretic activity in Mas-deficient mice establishes a physiological relevance to the binding and cell-culture studies identifying Mas as a functional receptor for Ang- (1) (2) (3) (4) (5) (6) (7) .
To demonstrate that the interaction of Ang-(1-7) and Mas is not restricted to the kidney, we investigated its relaxant ability in aortic rings of Mas-deficient animals. As previously shown in dogs and rats (25, 26) , vessels derived from WT animals relaxed after Ang-(1-7) treatment in a dose-dependent manner. However, Ang-(1-7) relaxation, but not endothelium-dependent relaxation of aortas by acetylcholine of Mas-knockout mice, was abolished. This is a previously undescribed demonstration of a molecular basis for the physiological actions of Ang-(1-7). Our findings will help to elucidate its interaction with Ang II (27, 28) , bradykinin (29, 30) , and angiotensin-converting enzyme (31) .
Further studies are underway to clarify to what extent other Ang-(1-7) actions, e.g., increased baroreflex sensitivity (32) , are mediated by its interaction with Mas. These studies will also determine whether phenotypic alterations in Mas-deficient mice, e.g., changes in heart rate, blood pressure variability (33, 34) , and behavioral anomalies (14, 35) , result from the absence of Ang-(1-7) actions.
Although our data cannot exclude indirect interaction of Mas and Ang II via the AT 1 receptor, they clearly demonstrate a direct interaction of Mas and Ang-(1-7). On the basis of our findings, we conclude that Mas binds Ang-(1-7) and is involved in mediating the biologic actions of this angiotensin peptide. These findings have clinical implications, because Ang-(1-7) counteracts Ang II and accumulates in patients treated with angiotensin-converting enzyme inhibitors (36) and thus may explain well demonstrated beneficial effects of these drugs. Our findings clearly widen the possibilities for treating cardiovascular diseases by using agonists for the Ang-(1-7)-Mas axis.
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